SGE CONSULTING will be attending the 2019 e-HEALTH World workshop in Monaco. A complete BtoB event combining scientific congress, exhibition and business meetings, e-Health World Monaco is the unmissable event for healthcare professionals and all their partners to discuss the issues of connected health, understand and share new practices, learn about emerging technologies and interactRead more about e-Health World Monaco on 26th and 27th of March 2019[…]

SGE Consulting will participate in the EPITEM Workshops organized in La Grande Motte, France, on March 28 and 29, 2019, during the 10th training seminar in pharmaco-epidemiology. These workshops are aimed at all stakeholders interested in Pharmaco-Epidemiology and the conduct of Post-Registration Studies of Health Products (Drugs and Medical Devices). The EPITEM workshops aim toRead more about EPITEM workshops on 28th and 29th of March 2019[…]

SGE Consulting attended the event organized by the Lab Santé Île de France on December 7 at the Chamber of Commerce: this association presented innovative health organizations that can be supported by the financing methods related to article 51 of the LFSS for 2018. The Île-de-France Health Lab is an innovation player and supports allRead more about LAB SANTÉ ÎLE DE FRANCE[…]

SGE CONSULTING SPEAKER for FRANCE Roundtable: Coverage with Evidence Development for innovative technologies. SGE Consulting debates about its experience and success regarding the innovation funding for breakthrough devices. Practical cases were presented by companies according to the HAS expectations regarding “Forfait Innovation” and long-term reimbursement. The RAPS conference was dedicated to the management of medicalRead more about Zurich, OCTOBER 30th, 2018 – European Medtech Reimbursement Roundtable – RAPS (Regulatory Affairs Professionals Society)[…]

In September 2018, the HAS gave a positive advice for the innovative funding dossier presented by SGE Consulting for EBR Systems, Inc.’s Wise CRT system. More in Device Med (french only)

VolitionRx Partners with Two Market Access Consulting Agencies to Support Market Access of NuQ(R) Colorectal Cancer Tests in Europe More… In this press relese, we said: “Market access and optimal reimbursement are critical considerations that require careful planning and strategic execution in the European Union given the diversity of the region’s governments, payers and regulatingRead more about VolitionRx press release[…]